Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair
Authors:
- Arsalan ShabbirASArsalan Shabbir
- Gen SuzukiGSGen Suzuki
- Techung LeeTLTechung Lee
- 1 December 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 390 (3) , 834-838
Abstract
No abstract availableKeywords
Funding Information
- NIH (HL84590)
- New York State Stem Cell Board
This publication has 41 references indexed in Scilit:
- Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cellsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimenAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Muscular Dystrophy Therapy by Nonautologous Mesenchymal Stem Cells: Muscle Regeneration Without Immunosuppression and InflammationTransplantation, 2009
- VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injuryJournal of Cellular and Molecular Medicine, 2008
- Endothelial Progenitor Cell Vascular Endothelial Growth Factor Gene Transfer for Vascular RegenerationCirculation, 2002
- Abnormalities of bone marrow mesenchymal cells in multiple myeloma patientsCancer, 2001
- Therapeutic angiogenesis in cardiology using protein formulationsCardiovascular Research, 2001
- VEGF Gene Delivery to MyocardiumCirculation, 2000
- Vascular ProtectionArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formationJACC, 2000